- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 217/06 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ringAlkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
Patent holdings for IPC class C07D 217/06
Total number of patents in this class: 267
10-year publication summary
|
17
|
16
|
12
|
18
|
17
|
16
|
15
|
15
|
18
|
4
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Neophore Limited | 17 |
9 |
| Boehringer Ingelheim International GmbH | 4642 |
8 |
| Opna Bio SA | 28 |
7 |
| Bristol-myers Squibb Company | 4880 |
5 |
| Astellas Pharma Inc. | 1087 |
5 |
| Conopco, Inc. | 5040 |
4 |
| Chugai Seiyaku Kabushiki Kaisha | 1362 |
4 |
| Jiangsu Hengrui Medicine Co., Ltd. | 707 |
4 |
| Minerva Neurosciences, Inc. | 57 |
4 |
| Respiratorius AB | 10 |
4 |
| Shanghai Hengrui Pharmaceutical Co., Ltd. | 641 |
4 |
| UDC Ireland Limited | 476 |
4 |
| Bausch + Lomb Ireland Limited | 695 |
4 |
| Shenzhen Cell Inspire Pharmaceutical Development Co., Ltd. | 8 |
4 |
| The Regents of the University of California | 19961 |
3 |
| Board of Regents, The University of Texas System | 5808 |
3 |
| Kaneka Corporation | 4534 |
3 |
| Takeda Pharmaceutical Company Limited | 2708 |
3 |
| Daiichi Sankyo Company, Limited | 1877 |
3 |
| Merial, Inc. | 220 |
3 |
| Other owners | 179 |